
Avadel Pharmaceuticals plc (AVDL) poses a Brand-New Opportunity for Investors with beta value of 1.45
Avadel Pharmaceuticals plc (NASDAQ: AVDL) started the day on Thursday, with a price decrease of -5.56% at $9.34, before settling in for the price of